| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis
|
Li, Jie
|
|
|
10 |
6 |
p. 573-583
|
artikel
|
| 2 |
Barriers to tuberculosis care in the Philippines
|
Dychiao, Robyn Gayle K
|
|
|
10 |
6 |
p. e55
|
artikel
|
| 3 |
Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
|
Wright, Bill J
|
|
|
10 |
6 |
p. 557-565
|
artikel
|
| 4 |
Concerns about PRISm
|
Knox-Brown, Ben
|
|
|
10 |
6 |
p. e51-e52
|
artikel
|
| 5 |
Correction to Lancet Respir Med 2022; 10: 545–56
|
|
|
|
10 |
6 |
p. e60
|
artikel
|
| 6 |
Correction to Lancet Respir Med 2022; published online Feb 25. https://doi.org/10.1016/S2213-2600(22)00045-5
|
|
|
|
10 |
6 |
p. e60
|
artikel
|
| 7 |
Dynamic zero COVID policy in the fight against COVID
|
Burki, Talha
|
|
|
10 |
6 |
p. e58-e59
|
artikel
|
| 8 |
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis
|
Baker, Jonathan R
|
|
|
10 |
6 |
p. 545-556
|
artikel
|
| 9 |
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
|
Rangaka, Molebogeng X
|
|
|
10 |
6 |
p. 529-531
|
artikel
|
| 10 |
European Congress of Clinical Microbiology & Infectious Diseases 2022
|
Venkatesan, Priya
|
|
|
10 |
6 |
p. e56-e57
|
artikel
|
| 11 |
How to survive a pandemic
|
Burki, Talha
|
|
|
10 |
6 |
p. 544
|
artikel
|
| 12 |
Inhaled corticosteroids: not just for asthma, but for COVID-19?
|
Liew, Felicity
|
|
|
10 |
6 |
p. 526-527
|
artikel
|
| 13 |
Making a case for investing in post-tuberculosis lung health in children
|
Nkereuwem, Esin
|
|
|
10 |
6 |
p. 536-537
|
artikel
|
| 14 |
Optimising tuberculosis care for refugees affected by armed conflicts
|
Castro, Kenneth G
|
|
|
10 |
6 |
p. 533-536
|
artikel
|
| 15 |
Paediatric pneumonia: catalysing research priorities for the next decade
|
King, Carina
|
|
|
10 |
6 |
p. 540-541
|
artikel
|
| 16 |
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis
|
Bowman, Willis S
|
|
|
10 |
6 |
p. 593-602
|
artikel
|
| 17 |
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
|
Turner, Steve
|
|
|
10 |
6 |
p. 584-592
|
artikel
|
| 18 |
Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure
|
Li, Qinyuan
|
|
|
10 |
6 |
p. e53
|
artikel
|
| 19 |
Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure – Authors' reply
|
Luo, Jian
|
|
|
10 |
6 |
p. e54
|
artikel
|
| 20 |
Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa
|
Apolisi, Ivy
|
|
|
10 |
6 |
p. 542-543
|
artikel
|
| 21 |
Tackling tuberculosis: what lies beneath the surface?
|
The Lancet Respiratory Medicine,
|
|
|
10 |
6 |
p. 525
|
artikel
|
| 22 |
The crucial need for tuberculosis translational research in the time of COVID-19
|
Loh, Fei Kean
|
|
|
10 |
6 |
p. 531-533
|
artikel
|
| 23 |
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
|
Dheda, Keertan
|
|
|
10 |
6 |
p. 603-622
|
artikel
|
| 24 |
The pandemic and the great awakening in the management of acute hypoxaemic respiratory failure
|
Shekar, Kiran
|
|
|
10 |
6 |
p. 527-529
|
artikel
|
| 25 |
Tuberculosis prevalence: beyond the tip of the iceberg
|
Houben, Rein M G J
|
|
|
10 |
6 |
p. 537-539
|
artikel
|
| 26 |
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
|
McKeigue, Paul M
|
|
|
10 |
6 |
p. 566-572
|
artikel
|
Tijdschrift beschrijving